Free Research Preview. DrugChatter may produce inaccurate information.
Save time and get answers to complex questions with AI chat
Should I take Vyvanse every day or take weekends off?Canakinumab biosimilar?How does grapefruit oil affect lipitor's effectiveness?How does generic xanax's chemical formula compare to brand name?Lipitor generics launch how was marketing affected?
See the DrugPatentWatch profile for aranesp
Who needs iron supplements with Aranesp? Aranesp is an erythropoiesis-stimulating agent (ESA) used to treat anemia related to chronic kidney disease, HIV infection, and chemotherapy. The medication works by stimulating the production of red blood cells in the body [1]. However, taking Aranesp can increase the risk of iron deficiency due to increased red blood cell production [2]. Iron supplements may be necessary for patients receiving Aranesp to maintain adequate iron levels and support red blood cell production. When to take iron supplements with Aranesp? According to the Aranesp manufacturer, patients with a low initial serum iron concentration (less than 50 μg/dL) and those who develop iron deficiency anemia during treatment may require iron supplements [3]. The recommended iron supplement dosage is typically 100-200 mg per day, taken orally [4]. Monitoring iron levels with Aranesp treatment Regular monitoring of iron levels is crucial while taking Aranesp to ensure that iron deficiency anemia is promptly identified and treated. Patients should have their iron levels checked regularly, and iron supplements should be started as needed to maintain adequate iron levels [5]. Sources: [1] Aranesp (darbepoetin alfa) prescribing information. Amgen Inc. Retrieved from https://www.accessdata.fda.gov/drugsatfdadocs/label/2007/020613s014lbl.pdf [2] Singh AK, et al. Aranesp (darbepoetin alfa) for the treatment of anemia in patients with chronic kidney disease. Journal of Clinical Pharmacology. 2006;46(3):343-355. [3] Aranesp (darbepoetin alfa) prescribing information. Amgen Inc. Retrieved from https://www.accessdata.fda.gov/drugsatfdadocs/label/2007/020613s014lbl.pdf [4] Clinicaltrials.gov. Study of anemia associated with renal disease. https://clinicaltrials.gov/ct2/show/NCT00001333 [5] U.S. National Library of Medicine. Darbepoetin alfa (Aranesp). MedlinePlus. https://medlineplus.gov/druginfo/meds/a605030.html
Other Questions About Aranesp :